This study investigated the biomarker potential of glutamine among known prognostic variables in localized prostate cancer.
Mourad Tighiouart, PhD
Advertisement
Articles by Mourad Tighiouart, PhD
Advertisement
Latest Updated Articles
Plasma Glutamine as a Prognostic Biomarker in Localized Prostate Cancer: Comparison of Conventional Variables in Risk StratificationPublished: September 14th 2021 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
FDA Approves Revumenib in R/R NPM1-Mutant AML
3
Awareness Fuels Progress: Upcoming Advances in Breast Cancer Treatment
4
FDA Approves Belantamab Mafodotin in R/R Multiple Myeloma
5
